0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Eluting Balloons (DEB) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-21T9094
Home | Market Reports | Health| Medical Devices & Equipment
Global Drug Eluting Balloons DEB Market Outlook 2022
BUY CHAPTERS

Global Drug Eluting Balloons (DEB) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-21T9094
Report
August 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Eluting Balloons (DEB) Sales Market Size

The global Drug Eluting Balloons (DEB) market size was US$ 746 million in 2024 and is forecast to a readjusted size of US$ 1745 million by 2031 with a CAGR of 13.1% during the forecast period 2025-2031.

Drug Eluting Balloons (DEB) Sales Market

Drug Eluting Balloons (DEB) Sales Market

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Drug Eluting Balloons (DEB) market competitiveness, regional economic performance, and supply chain configurations.
A drug-eluting balloon is a non-stent technology in which the effective homogenous delivery of anti-proliferative drugs is processed by the vessel wall through an inflated balloon. This is done to restore luminal vascularity in order to treat atherosclerosis, in-stent restenosis and reduce the risk of late thrombosis without implanting a permanent foreign object. The balloon technology relies on the concept of targeted drug delivery, which helps in the rapid healing of the vessel wall and prevents the proliferation of smooth muscle cells. Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure.
The Drug Eluting Balloons (DEB) market is being driven by the increasing global prevalence of cardiovascular diseases, particularly peripheral artery disease (PAD) and coronary artery disease (CAD). DEBs offer an effective alternative to traditional stents by delivering antiproliferative drugs directly to the vessel wall without leaving a permanent implant, reducing restenosis rates and improving long-term outcomes. Growing patient preference for minimally invasive procedures and shorter recovery times is also contributing to the adoption of DEBs. Furthermore, advancements in drug delivery technologies and increased clinical evidence supporting DEB efficacy are encouraging broader usage, especially among high-risk patients.
Despite their benefits, the DEB market faces several challenges. One key issue is the lack of uniform clinical guidelines and inconsistent results from clinical trials, which may hinder physician confidence and limit widespread adoption. Additionally, the high cost of DEBs compared to conventional balloons or bare-metal stents can be a barrier, particularly in emerging economies with limited healthcare budgets. Regulatory complexities and lengthy approval processes also pose significant hurdles for manufacturers. Furthermore, reimbursement policies vary across regions, creating market access disparities and limiting patient availability to these advanced therapies.
The DEB market is witnessing key trends such as the development of next-generation balloons with enhanced drug coatings and more efficient drug release profiles. There is growing interest in DEBs for treating new indications beyond peripheral and coronary artery disease, such as in-stent restenosis, small vessel disease, and arteriovenous fistula stenosis. Integration of imaging technologies, like intravascular ultrasound (IVUS) and optical coherence tomography (OCT), is also improving procedural outcomes. Additionally, strategic collaborations between medtech companies and research institutions are accelerating innovation, while increasing focus on personalized medicine is expected to drive customized DEB solutions in the near future.
Global Drug Eluting Balloons(DEB) key players include B. Braun, Medtronic, Boston Scientific, BD, Yinyi, etc. Global top 5 manufacturers hold a share over 84%. Europe is the largest market, with a share about 42%, followed by North America, and Asia-Pacific, both have a share about 52 percent.
The global Drug Eluting Balloons (DEB) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation

Scope of Drug Eluting Balloons (DEB) Sales Market Report

Report Metric Details
Report Name Drug Eluting Balloons (DEB) Sales Market
Forecasted market size in 2031 US$ 1745 million
CAGR 13.1%
Forecasted years 2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)
By Application: (Core Demand Driver vs Emerging Opportunity)
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company: B. Braun, Medtronic, Boston Scientific, BD, Yinyi, Philips, Eurocor, Aachen Resonance, Biotronic
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
  • Chapter 2: Quantitative analysis of Drug Eluting Balloons (DEB) market size and growth potential at global, regional, and country levels.
  • Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
  • Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Coronary DEBs in China).
  • Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Hospital in India).
  • Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
  • Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
  • Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 9: Actionable conclusions and strategic recommendations.
  • Why This Report?
  • Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Drug Eluting Balloons (DEB) value chain, addressing:

FAQ for this report

What is the Drug Eluting Balloons (DEB) Sales Market size in 2031?

Ans: The Drug Eluting Balloons (DEB) Sales Market size in 2031 will be US$ 1745 million.

What is the market share of major companies in Drug Eluting Balloons (DEB) Sales Market?

Ans: Global top 5 manufacturers hold a share over 84%.

Who are the main players in the Drug Eluting Balloons (DEB) Sales Market report?

Ans: The main players in the Drug Eluting Balloons (DEB) Sales Market are B. Braun, Medtronic, Boston Scientific, BD, Yinyi, Philips, Eurocor, Aachen Resonance, Biotronic

What are the Application segmentation covered in the Drug Eluting Balloons (DEB) Sales Market report?

Ans: The Applications covered in the Drug Eluting Balloons (DEB) Sales Market report are Catheterization Laboratory, Hospital, Others

What are the Type segmentation covered in the Drug Eluting Balloons (DEB) Sales Market report?

Ans: The Types covered in the Drug Eluting Balloons (DEB) Sales Market report are Peripheral DEBs, Coronary DEBs

Recommended Reports

Balloon Catheters

Drug Eluting Stents

Angioplasty Balloons

1 Market Overview
1.1 Drug Eluting Balloons (DEB) Product Scope
1.2 Drug Eluting Balloons (DEB) by Type
1.2.1 Global Drug Eluting Balloons (DEB) Sales by Type (2020 & 2024 & 2031)
1.2.2 Peripheral DEBs
1.2.3 Coronary DEBs
1.3 Drug Eluting Balloons (DEB) by Application
1.3.1 Global Drug Eluting Balloons (DEB) Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Catheterization Laboratory
1.3.3 Hospital
1.3.4 Others
1.4 Global Drug Eluting Balloons (DEB) Market Estimates and Forecasts (2020-2031)
1.4.1 Global Drug Eluting Balloons (DEB) Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Drug Eluting Balloons (DEB) Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Drug Eluting Balloons (DEB) Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Drug Eluting Balloons (DEB) Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Drug Eluting Balloons (DEB) Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Drug Eluting Balloons (DEB) Sales Market Share by Region (2020-2025)
2.2.2 Global Drug Eluting Balloons (DEB) Revenue Market Share by Region (2020-2025)
2.3 Global Drug Eluting Balloons (DEB) Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Drug Eluting Balloons (DEB) Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Drug Eluting Balloons (DEB) Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Drug Eluting Balloons (DEB) Market Size and Prospective (2020-2031)
2.4.2 Europe Drug Eluting Balloons (DEB) Market Size and Prospective (2020-2031)
2.4.3 China Drug Eluting Balloons (DEB) Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Drug Eluting Balloons (DEB) Historic Market Review by Type (2020-2025)
3.1.1 Global Drug Eluting Balloons (DEB) Sales by Type (2020-2025)
3.1.2 Global Drug Eluting Balloons (DEB) Revenue by Type (2020-2025)
3.1.3 Global Drug Eluting Balloons (DEB) Price by Type (2020-2025)
3.2 Global Drug Eluting Balloons (DEB) Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Drug Eluting Balloons (DEB) Sales Forecast by Type (2026-2031)
3.2.2 Global Drug Eluting Balloons (DEB) Revenue Forecast by Type (2026-2031)
3.2.3 Global Drug Eluting Balloons (DEB) Price Forecast by Type (2026-2031)
3.3 Different Types Drug Eluting Balloons (DEB) Representative Players
4 Global Market Size by Application
4.1 Global Drug Eluting Balloons (DEB) Historic Market Review by Application (2020-2025)
4.1.1 Global Drug Eluting Balloons (DEB) Sales by Application (2020-2025)
4.1.2 Global Drug Eluting Balloons (DEB) Revenue by Application (2020-2025)
4.1.3 Global Drug Eluting Balloons (DEB) Price by Application (2020-2025)
4.2 Global Drug Eluting Balloons (DEB) Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Drug Eluting Balloons (DEB) Sales Forecast by Application (2026-2031)
4.2.2 Global Drug Eluting Balloons (DEB) Revenue Forecast by Application (2026-2031)
4.2.3 Global Drug Eluting Balloons (DEB) Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Drug Eluting Balloons (DEB) Application
5 Competition Landscape by Players
5.1 Global Drug Eluting Balloons (DEB) Sales by Players (2020-2025)
5.2 Global Top Drug Eluting Balloons (DEB) Players by Revenue (2020-2025)
5.3 Global Drug Eluting Balloons (DEB) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Balloons (DEB) as of 2024)
5.4 Global Drug Eluting Balloons (DEB) Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Drug Eluting Balloons (DEB), Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Drug Eluting Balloons (DEB), Product Type & Application
5.7 Global Key Manufacturers of Drug Eluting Balloons (DEB), Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Drug Eluting Balloons (DEB) Sales by Company
6.1.1.1 North America Drug Eluting Balloons (DEB) Sales by Company (2020-2025)
6.1.1.2 North America Drug Eluting Balloons (DEB) Revenue by Company (2020-2025)
6.1.2 North America Drug Eluting Balloons (DEB) Sales Breakdown by Type (2020-2025)
6.1.3 North America Drug Eluting Balloons (DEB) Sales Breakdown by Application (2020-2025)
6.1.4 North America Drug Eluting Balloons (DEB) Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Drug Eluting Balloons (DEB) Sales by Company
6.2.1.1 Europe Drug Eluting Balloons (DEB) Sales by Company (2020-2025)
6.2.1.2 Europe Drug Eluting Balloons (DEB) Revenue by Company (2020-2025)
6.2.2 Europe Drug Eluting Balloons (DEB) Sales Breakdown by Type (2020-2025)
6.2.3 Europe Drug Eluting Balloons (DEB) Sales Breakdown by Application (2020-2025)
6.2.4 Europe Drug Eluting Balloons (DEB) Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Drug Eluting Balloons (DEB) Sales by Company
6.3.1.1 China Drug Eluting Balloons (DEB) Sales by Company (2020-2025)
6.3.1.2 China Drug Eluting Balloons (DEB) Revenue by Company (2020-2025)
6.3.2 China Drug Eluting Balloons (DEB) Sales Breakdown by Type (2020-2025)
6.3.3 China Drug Eluting Balloons (DEB) Sales Breakdown by Application (2020-2025)
6.3.4 China Drug Eluting Balloons (DEB) Major Customer
6.3.5 China Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 B. Braun
7.1.1 B. Braun Company Information
7.1.2 B. Braun Business Overview
7.1.3 B. Braun Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2020-2025)
7.1.4 B. Braun Drug Eluting Balloons (DEB) Products Offered
7.1.5 B. Braun Recent Development
7.2 Medtronic
7.2.1 Medtronic Company Information
7.2.2 Medtronic Business Overview
7.2.3 Medtronic Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Medtronic Drug Eluting Balloons (DEB) Products Offered
7.2.5 Medtronic Recent Development
7.3 Boston Scientific
7.3.1 Boston Scientific Company Information
7.3.2 Boston Scientific Business Overview
7.3.3 Boston Scientific Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Boston Scientific Drug Eluting Balloons (DEB) Products Offered
7.3.5 Boston Scientific Recent Development
7.4 BD
7.4.1 BD Company Information
7.4.2 BD Business Overview
7.4.3 BD Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2020-2025)
7.4.4 BD Drug Eluting Balloons (DEB) Products Offered
7.4.5 BD Recent Development
7.5 Yinyi
7.5.1 Yinyi Company Information
7.5.2 Yinyi Business Overview
7.5.3 Yinyi Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Yinyi Drug Eluting Balloons (DEB) Products Offered
7.5.5 Yinyi Recent Development
7.6 Philips
7.6.1 Philips Company Information
7.6.2 Philips Business Overview
7.6.3 Philips Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Philips Drug Eluting Balloons (DEB) Products Offered
7.6.5 Philips Recent Development
7.7 Eurocor
7.7.1 Eurocor Company Information
7.7.2 Eurocor Business Overview
7.7.3 Eurocor Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Eurocor Drug Eluting Balloons (DEB) Products Offered
7.7.5 Eurocor Recent Development
7.8 Aachen Resonance
7.8.1 Aachen Resonance Company Information
7.8.2 Aachen Resonance Business Overview
7.8.3 Aachen Resonance Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Aachen Resonance Drug Eluting Balloons (DEB) Products Offered
7.8.5 Aachen Resonance Recent Development
7.9 Biotronic
7.9.1 Biotronic Company Information
7.9.2 Biotronic Business Overview
7.9.3 Biotronic Drug Eluting Balloons (DEB) Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Biotronic Drug Eluting Balloons (DEB) Products Offered
7.9.5 Biotronic Recent Development
8 Drug Eluting Balloons (DEB) Manufacturing Cost Analysis
8.1 Drug Eluting Balloons (DEB) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Drug Eluting Balloons (DEB)
8.4 Drug Eluting Balloons (DEB) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Drug Eluting Balloons (DEB) Distributors List
9.3 Drug Eluting Balloons (DEB) Customers
10 Drug Eluting Balloons (DEB) Market Dynamics
10.1 Drug Eluting Balloons (DEB) Industry Trends
10.2 Drug Eluting Balloons (DEB) Market Drivers
10.3 Drug Eluting Balloons (DEB) Market Challenges
10.4 Drug Eluting Balloons (DEB) Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
 Table 1. Global Drug Eluting Balloons (DEB) Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
 Table 2. Global Drug Eluting Balloons (DEB) Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
 Table 3. Global Market Drug Eluting Balloons (DEB) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Table 4. Global Drug Eluting Balloons (DEB) Sales (K Units) by Region (2020-2025)
 Table 5. Global Drug Eluting Balloons (DEB) Sales Market Share by Region (2020-2025)
 Table 6. Global Drug Eluting Balloons (DEB) Revenue (US$ Million) Market Share by Region (2020-2025)
 Table 7. Global Drug Eluting Balloons (DEB) Revenue Share by Region (2020-2025)
 Table 8. Global Drug Eluting Balloons (DEB) Sales (K Units) Forecast by Region (2026-2031)
 Table 9. Global Drug Eluting Balloons (DEB) Sales Market Share Forecast by Region (2026-2031)
 Table 10. Global Drug Eluting Balloons (DEB) Revenue (US$ Million) Forecast by Region (2026-2031)
 Table 11. Global Drug Eluting Balloons (DEB) Revenue Share Forecast by Region (2026-2031)
 Table 12. Global Drug Eluting Balloons (DEB) Sales by Type (K Units) & (2020-2025)
 Table 13. Global Drug Eluting Balloons (DEB) Sales Share by Type (2020-2025)
 Table 14. Global Drug Eluting Balloons (DEB) Revenue by Type (US$ Million) & (2020-2025)
 Table 15. Global Drug Eluting Balloons (DEB) Price by Type (US$/Unit) & (2020-2025)
 Table 16. Global Drug Eluting Balloons (DEB) Sales by Type (K Units) & (2026-2031)
 Table 17. Global Drug Eluting Balloons (DEB) Revenue by Type (US$ Million) & (2026-2031)
 Table 18. Global Drug Eluting Balloons (DEB) Price by Type (US$/Unit) & (2026-2031)
 Table 19. Representative Players of Each Type
 Table 20. Global Drug Eluting Balloons (DEB) Sales by Application (K Units) & (2020-2025)
 Table 21. Global Drug Eluting Balloons (DEB) Sales Share by Application (2020-2025)
 Table 22. Global Drug Eluting Balloons (DEB) Revenue by Application (US$ Million) & (2020-2025)
 Table 23. Global Drug Eluting Balloons (DEB) Price by Application (US$/Unit) & (2020-2025)
 Table 24. Global Drug Eluting Balloons (DEB) Sales by Application (K Units) & (2026-2031)
 Table 25. Global Drug Eluting Balloons (DEB) Revenue Market Share by Application (US$ Million) & (2026-2031)
 Table 26. Global Drug Eluting Balloons (DEB) Price by Application (US$/Unit) & (2026-2031)
 Table 27. New Sources of Growth in Drug Eluting Balloons (DEB) Application
 Table 28. Global Drug Eluting Balloons (DEB) Sales by Company (K Units) & (2020-2025)
 Table 29. Global Drug Eluting Balloons (DEB) Sales Share by Company (2020-2025)
 Table 30. Global Drug Eluting Balloons (DEB) Revenue by Company (US$ Million) & (2020-2025)
 Table 31. Global Drug Eluting Balloons (DEB) Revenue Share by Company (2020-2025)
 Table 32. Global Drug Eluting Balloons (DEB) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Balloons (DEB) as of 2024)
 Table 33. Global Market Drug Eluting Balloons (DEB) Average Price by Company (US$/Unit) & (2020-2025)
 Table 34. Global Key Manufacturers of Drug Eluting Balloons (DEB), Manufacturing Sites & Headquarters
 Table 35. Global Key Manufacturers of Drug Eluting Balloons (DEB), Product Type & Application
 Table 36. Global Key Manufacturers of Drug Eluting Balloons (DEB), Date of Enter into This Industry
 Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 38. North America Drug Eluting Balloons (DEB) Sales by Company (2020-2025) & (K Units)
 Table 39. North America Drug Eluting Balloons (DEB) Sales Market Share by Company (2020-2025)
 Table 40. North America Drug Eluting Balloons (DEB) Revenue by Company (2020-2025) & (US$ Million)
 Table 41. North America Drug Eluting Balloons (DEB) Revenue Market Share by Company (2020-2025)
 Table 42. North America Drug Eluting Balloons (DEB) Sales by Type (2020-2025) & (K Units)
 Table 43. North America Drug Eluting Balloons (DEB) Sales Market Share by Type (2020-2025)
 Table 44. North America Drug Eluting Balloons (DEB) Sales by Application (2020-2025) & (K Units)
 Table 45. North America Drug Eluting Balloons (DEB) Sales Market Share by Application (2020-2025)
 Table 46. Europe Drug Eluting Balloons (DEB) Sales by Company (2020-2025) & (K Units)
 Table 47. Europe Drug Eluting Balloons (DEB) Sales Market Share by Company (2020-2025)
 Table 48. Europe Drug Eluting Balloons (DEB) Revenue by Company (2020-2025) & (US$ Million)
 Table 49. Europe Drug Eluting Balloons (DEB) Revenue Market Share by Company (2020-2025)
 Table 50. Europe Drug Eluting Balloons (DEB) Sales by Type (2020-2025) & (K Units)
 Table 51. Europe Drug Eluting Balloons (DEB) Sales Market Share by Type (2020-2025)
 Table 52. Europe Drug Eluting Balloons (DEB) Sales by Application (2020-2025) & (K Units)
 Table 53. Europe Drug Eluting Balloons (DEB) Sales Market Share by Application (2020-2025)
 Table 54. China Drug Eluting Balloons (DEB) Sales by Company (2020-2025) & (K Units)
 Table 55. China Drug Eluting Balloons (DEB) Sales Market Share by Company (2020-2025)
 Table 56. China Drug Eluting Balloons (DEB) Revenue by Company (2020-2025) & (US$ Million)
 Table 57. China Drug Eluting Balloons (DEB) Revenue Market Share by Company (2020-2025)
 Table 58. China Drug Eluting Balloons (DEB) Sales by Type (2020-2025) & (K Units)
 Table 59. China Drug Eluting Balloons (DEB) Sales Market Share by Type (2020-2025)
 Table 60. China Drug Eluting Balloons (DEB) Sales by Application (2020-2025) & (K Units)
 Table 61. China Drug Eluting Balloons (DEB) Sales Market Share by Application (2020-2025)
 Table 62. B. Braun Company Information
 Table 63. B. Braun Description and Business Overview
 Table 64. B. Braun Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 65. B. Braun Drug Eluting Balloons (DEB) Product
 Table 66. B. Braun Recent Development
 Table 67. Medtronic Company Information
 Table 68. Medtronic Description and Business Overview
 Table 69. Medtronic Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 70. Medtronic Drug Eluting Balloons (DEB) Product
 Table 71. Medtronic Recent Development
 Table 72. Boston Scientific Company Information
 Table 73. Boston Scientific Description and Business Overview
 Table 74. Boston Scientific Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Boston Scientific Drug Eluting Balloons (DEB) Product
 Table 76. Boston Scientific Recent Development
 Table 77. BD Company Information
 Table 78. BD Description and Business Overview
 Table 79. BD Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. BD Drug Eluting Balloons (DEB) Product
 Table 81. BD Recent Development
 Table 82. Yinyi Company Information
 Table 83. Yinyi Description and Business Overview
 Table 84. Yinyi Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. Yinyi Drug Eluting Balloons (DEB) Product
 Table 86. Yinyi Recent Development
 Table 87. Philips Company Information
 Table 88. Philips Description and Business Overview
 Table 89. Philips Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Philips Drug Eluting Balloons (DEB) Product
 Table 91. Philips Recent Development
 Table 92. Eurocor Company Information
 Table 93. Eurocor Description and Business Overview
 Table 94. Eurocor Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. Eurocor Drug Eluting Balloons (DEB) Product
 Table 96. Eurocor Recent Development
 Table 97. Aachen Resonance Company Information
 Table 98. Aachen Resonance Description and Business Overview
 Table 99. Aachen Resonance Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 100. Aachen Resonance Drug Eluting Balloons (DEB) Product
 Table 101. Aachen Resonance Recent Development
 Table 102. Biotronic Company Information
 Table 103. Biotronic Description and Business Overview
 Table 104. Biotronic Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 105. Biotronic Drug Eluting Balloons (DEB) Product
 Table 106. Biotronic Recent Development
 Table 107. Production Base and Market Concentration Rate of Raw Material
 Table 108. Key Suppliers of Raw Materials
 Table 109. Drug Eluting Balloons (DEB) Distributors List
 Table 110. Drug Eluting Balloons (DEB) Customers List
 Table 111. Drug Eluting Balloons (DEB) Market Trends
 Table 112. Drug Eluting Balloons (DEB) Market Drivers
 Table 113. Drug Eluting Balloons (DEB) Market Challenges
 Table 114. Drug Eluting Balloons (DEB) Market Restraints
 Table 115. Research Programs/Design for This Report
 Table 116. Key Data Information from Secondary Sources
 Table 117. Key Data Information from Primary Sources


List of Figures
 Figure 1. Drug Eluting Balloons (DEB) Product Picture
 Figure 2. Global Drug Eluting Balloons (DEB) Sales (US$ Million) by Type (2020 & 2024 & 2031)
 Figure 3. Global Drug Eluting Balloons (DEB) Sales Market Share by Type in 2024 & 2031
 Figure 4. Peripheral DEBs Product Picture
 Figure 5. Coronary DEBs Product Picture
 Figure 6. Global Drug Eluting Balloons (DEB) Sales (US$ Million) by Application (2020 & 2024 & 2031)
 Figure 7. Global Drug Eluting Balloons (DEB) Sales Market Share by Application in 2024 & 2031
 Figure 8. Catheterization Laboratory Examples
 Figure 9. Hospital Examples
 Figure 10. Others Examples
 Figure 11. Global Drug Eluting Balloons (DEB) Sales, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Drug Eluting Balloons (DEB) Sales Growth Rate (2020-2031) & (US$ Million)
 Figure 13. Global Drug Eluting Balloons (DEB) Sales (K Units) Growth Rate (2020-2031)
 Figure 14. Global Drug Eluting Balloons (DEB) Price Trends Growth Rate (2020-2031) & (US$/Unit)
 Figure 15. Drug Eluting Balloons (DEB) Report Years Considered
 Figure 16. Global Market Drug Eluting Balloons (DEB) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Figure 17. Global Drug Eluting Balloons (DEB) Revenue Market Share by Region: 2020 VS 2024
 Figure 18. North America Drug Eluting Balloons (DEB) Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 19. North America Drug Eluting Balloons (DEB) Sales (K Units) Growth Rate (2020-2031)
 Figure 20. Europe Drug Eluting Balloons (DEB) Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 21. Europe Drug Eluting Balloons (DEB) Sales (K Units) Growth Rate (2020-2031)
 Figure 22. China Drug Eluting Balloons (DEB) Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 23. China Drug Eluting Balloons (DEB) Sales (K Units) Growth Rate (2020-2031)
 Figure 24. Global Drug Eluting Balloons (DEB) Revenue Share by Type (2020-2025)
 Figure 25. Global Drug Eluting Balloons (DEB) Sales Share by Type (2026-2031)
 Figure 26. Global Drug Eluting Balloons (DEB) Revenue Share by Type (2026-2031)
 Figure 27. Global Drug Eluting Balloons (DEB) Revenue Share by Application (2020-2025)
 Figure 28. Global Drug Eluting Balloons (DEB) Revenue Growth Rate by Application in 2020 & 2024
 Figure 29. Global Drug Eluting Balloons (DEB) Sales Share by Application (2026-2031)
 Figure 30. Global Drug Eluting Balloons (DEB) Revenue Share by Application (2026-2031)
 Figure 31. Global Drug Eluting Balloons (DEB) Sales Share by Company (2024)
 Figure 32. Global Drug Eluting Balloons (DEB) Revenue Share by Company (2024)
 Figure 33. Global 5 Largest Drug Eluting Balloons (DEB) Players Market Share by Revenue in Drug Eluting Balloons (DEB): 2020 & 2024
 Figure 34. Drug Eluting Balloons (DEB) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 35. Manufacturing Cost Structure of Drug Eluting Balloons (DEB)
 Figure 36. Manufacturing Process Analysis of Drug Eluting Balloons (DEB)
 Figure 37. Drug Eluting Balloons (DEB) Industrial Chain
 Figure 38. Channels of Distribution (Direct Vs Distribution)
 Figure 39. Distributors Profiles
 Figure 40. Bottom-up and Top-down Approaches for This Report
 Figure 41. Data Triangulation
 Figure 42. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4250

This license allows only one user to access the PDF.
Electronic (PDF)

$6000

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8000

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart